Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Papillary thyroid cancer laboratory findings
Introduction
Overview
Overview
Laboratory findings consistent with the diagnosis of papillary thyroid cancer include presence of tumor markers such as thyroglobulin. Thyroglobulin can be used as a tumor marker for well-differentiated papillary thyroid cancer.
Laboratory Findings
Laboratory Findings
- Laboratory findings consistent with the diagnosis of papillary thyroid cancer include presence of tumor markers such as thyroglobulin. Thyroglobulin can be used as a tumor marker for well-differentiated papillary thyroid cancer.[1][2]
- Reduced expression of ATP5E is significantly associated with the diagnosis of papillary thyroid cancer and may serve as an early tumor marker of the disease.[3]
- Thyroid cancer rarely affects thyroid endocrine function. Therefore, thyroid function test is not diagnostic for the papillary thyroid cancer.[4]
References
References
- ↑ Lin JD (2007). “Thyroglobulin and human thyroid cancer”. Clin Chim Acta. 388 (1–2): 15–21. doi:10.1016/j.cca.2007.11.002. PMID 18060877.
- ↑ Tuttle RM, Leboeuf R, Martorella AJ (2007). “Papillary thyroid cancer: monitoring and therapy”. Endocrinol. Metab. Clin. North Am. 36 (3): 753–78, vii. doi:10.1016/j.ecl.2007.04.004. PMID 17673127.
- ↑ Hurtado-López, LM; Fernández-RamÃrez, F; MartÃnez-Peñafiel, E; Carrillo Ruiz, JD; Herrera González, NE (16 June 2015). “Molecular Analysis by Gene Expression of Mitochondrial ATPase Subunits in Papillary Thyroid Cancer: Is ATP5E Transcript a Possible Early Tumor Marker?”. Medical science monitor : international medical journal of experimental and clinical research. 21: 1745–51. PMID 26079849.
- ↑ DeLellis, Ronald (2004). Pathology and genetics of tumours of endocrine organs. Lyon: IARC Press. ISBN 92-832-2416-7.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2] Sahar Memar Montazerin, M.D.[3]